Loading
institutionsInstitution
Centre Antoine Lacassagne
Nice's cancer centre and a proton therapy pioneer in France, treating eye melanoma with protons since 1991.
Also called: CAL
Overview
Founded in 1961, the Centre Antoine Lacassagne is the UNICANCER centre for the Côte d'Azur. Its Institut Méditerranéen de Protonthérapie began treating uveal melanoma with the MEDICYC low-energy cyclotron in 1991 and added a high-energy IBA ProteusONE system in 2016, making it one of France's few proton facilities and a reference for ocular and paediatric tumours. Other programmes include head and neck oncology, breast surgery, nuclear medicine and an early-phase unit. Research with the Université Côte d'Azur focuses on radiobiology and medical physics.
Location
Nice, FR
Type
cancer center · Université Côte d'Azur
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#328 · 20 points (0 Newsweek + 0 NCI + 20 from 10 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Centre Antoine Lacassagne, including child institutions. 251 works · 3,260 citations · 71% open access · 18% clinical trials · 1% reviews.
Oncology works per year
662022
602023
572024
452025
232026
Most works
- Ludovic Evesque26 works
- Philippe Follana23 works
- Jean‐Sébastien Frenel19 works
- Renaud Schiappa19 works
- François Ghiringhelli17 works
- Anthony Gonçalvès14 works
- Christelle de la Fouchardière14 works
- Jean‐Baptiste Bachet14 works
- Méher Ben Abdelghani13 works
- Jean-Marc Ferrero13 works
Most cited
- Proton therapy (Institut Méditerranéen de Protonthérapie)
- Uveal melanoma
- Head and neck cancer
- Nuclear medicine
Emmanuel Barranger
Directeur Général of the Centre Antoine Lacassagne
Cancer centre leadershipComprehensive cancer careHospital governance
Professor who runs the Centre Antoine Lacassagne, the regional cancer centre in Nice, as its Directeur Général.
Joël Guigay
Medical oncologist, Centre Antoine Lacassagne, Nice
Head and neck cancerChemotherapy regimensGORTEC trials
Nice oncologist who led TPExtreme, the GORTEC trial that showed the shorter TPEx regimen is a reasonable alternative to EXTREME for recurrent or metastatic head and neck cancer.
Similar pages
- TechnologyProton arc therapy
Shares IBA (Ion Beam Applications), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, IMRT / IGRT (modern external beam).
- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.
- CompanyLeo Cancer Care
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, IMRT / IGRT (modern external beam).
- JournalClinical breast cancer
Shares Emmanuel Barranger, HR-positive / HER2-negative breast cancer.
- InstitutionShandong Cancer Hospital and Institute
Shares PET/CT, Proton therapy, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
- InstitutionHokkaido University Hospital
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
- CompanyP-Cure
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy, IMRT / IGRT (modern external beam).
- IdeaA coordinated FLASH radiotherapy evidence programme with shared dose-rate standards
Shares IBA (Ion Beam Applications), Proton therapy, Head and neck squamous cell carcinoma.